A phase 2 trial of ponatinib in P…-positive leukemias.

🔬 Peer-reviewed

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

Cortes JE, Kim DW, Pinilla-Ibarz J, le Coutre P, Paquette R et al.

The New England journal of medicine · 2013

Findings

PubMed study on Isoleucine in cosmetics/dermatology

Design

Clinical Trial (Phase II)

Evidence

Moderate

Journal

The New England journal of medicine

Ingredients studied